Our suite of CDMO solutions is designed to provide everything you need, from cell line development to fill and finish. With a fully-integrated approach to your product, we provide you with a single, direct and streamlined route to market.
A platform that pushes your project further
Unlocking higher yields across a range of biologics at significantly lower costs to you, our patented continuous bioprocess manufacturing platform represents the pinnacle of our ongoing commitment to innovation.
EnzeneX™ harnesses the power of intensified perfusion using alternate tangential flow (ATF) and automated multi-column chromatography to achieve the continuous production of your biologics.
Designed for efficiency and cost-effectiveness, EnzeneX™ enables uninterrupted loading and processing of materials, delivering superior product quality and manufacturing outcomes.
We are a global CDMO and biosimilar developer dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX™, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars are designed to cater to your project’s every need.
Explore the latest resources to gain insights from our experts, keep up with the latest industry trends and learn more about our innovative solutions.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.